Abstract
Introduction
The present study aimed to evaluate the effects of FTY720 as a neuromodulatory drug on the behaviors of neural stem/progenitor cells (NS/PCs) in two-dimensional (2-D) and three-dimensional (3-D) cultures and in spinal cord injury (SCI).
Methods
The NS/PCs isolated from the ganglionic eminence of the 13.5-day old embryos were cultured as free-floating spheres. The single cells obtained from the second passage were cultured in 96-well plates without any scaffold (2-D) or containing PuraMatrix (PM, 3-D) or were used for transplantation in a mouse model of compression SCI. After exposure to 0, 10, 50, and 100 nanomolar of FTY720, the survival, proliferation, and migration of the NS/PCs were evaluated in vitro using MTT assay, neurosphere assay, and migration assay, respectively. Moreover, the functional recovery, survival and migration capacity of transplanted cells exposure to 100 nanomolar FTY720 were investigated in SCI.
Results
Cell survival and migration capacity increased after exposure to 50 and 100 nanomolar FTY720. In addition, higher doses of FTY720 led to the formation of more extensive and more neurospheres. Although this phenomenon was similar in both 2-D and 3-D cultures, PM induced better distribution of the cells in a 3-D environment. Furthermore, co-administration of FTY720 and NS/PCs 7 days after SCI enhanced functional recovery and both survival and migration of transplanted cells in the lesion site.
Conclusions
Due to the positive effects of FTY720 on the behavior of NS/PCs, using them in combination therapies can be an appealing approach for stem cell therapy in CNS injury.
Similar content being viewed by others
References
Ahuja, C. S., J. R. Wilson, S. Nori, M. R. Kotter, C. Druschel, A. Curt, and M. G. Fehlings. Traumatic spinal cord injury. Nat. Rev. Dis. Primers. 3:1–21, 2017.
Aligholi, H., S. M. Rezayat, H. Azari, S. E. Mehr, M. Akbari, S. M. M. Mousavi, et al. Preparing neural stem/progenitor cells in PuraMatrix hydrogel for transplantation after brain injury in rats. A comparative methodological study. Brain Res. 1642:197–208, 2016.
Azari, H., S. Sharififar, M. Rahman, S. Ansari, and B. A. Reynolds. Establishing embryonic mouse neural stem cell culture using the neurosphere assay. J. Vis. Exp. 47:2457, 2011.
Basso, D. M., L. C. Fisher, A. J. Anderson, L. B. Jakeman, D. M. Mctigue, and P. G. Popovich. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma. 23(5):635–659, 2006.
Blaho, V. A., and T. Hla. An update on the biology of sphingosine 1-phosphate receptors. J. Lipid Res. 55(8):1596–1608, 2014.
Brait, V. H., G. Tarrasón, A. Gavaldà, N. Godessart, and A. M. Planas. Selective sphingosine 1-phosphate receptor 1 agonist is protective against ischemia/reperfusion in mice. Stroke. 47(12):3053–3056, 2016.
Choo, A. M., J. Liu, M. Dvorak, W. Tetzlaff, and T. R. Oxland. Secondary pathology following contusion, dislocation, and distraction spinal cord injuries. Exp. Neurol. 212(2):490–506, 2008.
Danielyan, L., M. Schwab, G. Siegel, B. Brawek, O. Garaschuk, and N. Asavapanumas. Cell motility and migration as determinants of stem cell efficacy. EBioMedicine. 60:102989, 2020.
Gage, F. H. Mammalian neural stem cells. Science. 287(5457):1433–1438, 2000.
Harada, J., M. Foley, M. A. Moskowitz, and C. Waeber. Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. J. Neurochem. 88(4):1026–1039, 2004.
Hasegawa, Y., H. Suzuki, T. Sozen, W. Rolland, and J. H. Zhang. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke. 41(2):368–374, 2010.
Hemmati, F., L. Dargahi, S. Nasoohi, R. Omidbakhsh, Z. Mohamed, Z. Chik, et al. Neurorestorative effect of FTY720 in a rat model of Alzheimer’s disease: comparison with memantine. Behav. Brain Res. 252:415–421, 2013.
Kappos, L., J. Antel, G. Comi, X. Montalban, P. O’connor, and C. H. Polman. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 355(11):1124–1140, 2006.
Kassmer, S. H., D. Rodriguez, A. D. Langenbacher, C. Bui, and A. W. De Tomaso. Migration of germline progenitor cells is directed by sphingosine-1-phosphate signalling in a basal chordate. Nat. Commun. 6(1):1–10, 2015.
Kim, S. U., H. J. Lee, and Y. B. Kim. Neural stem cell-based treatment for neurodegenerative diseases. Neuropathology. 33(5):491–504, 2013.
Kimura, A., T. Ohmori, R. Ohkawa, S. Madoiwa, J. Mimuro, T. Murakami, et al. Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells. 25(1):115–124, 2007.
Kong, W., Z. Qi, P. Xia, Y. Chang, H. Li, Y. Qu, et al. Local delivery of FTY720 and NSCs on electrospun PLGA scaffolds improves functional recovery after spinal cord injury. RSC Adv. 9(31):17801–17811, 2019.
Lee, K. D., W. N. Chow, C. Sato-Bigbee, M. R. Graf, R. S. Graham, R. J. Colello, et al. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J. Neurotrauma. 26(12):2335–2344, 2009.
Lu, L., A. H. Barfejani, T. Qin, Q. Dong, C. Ayata, and C. Waeber. Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage. Brain Res. 1555:89–96, 2014.
Marsh, S. E., and M. Blurton-Jones. Neural stem cell therapy for neurodegenerative disorders: the role of neurotrophic support. Neurochem. Int. 106:94–100, 2017.
Negah, S. S., Z. Khaksar, H. Aligholi, S. M. Sadeghi, S. M. M. Mousavi, H. Kazemi, et al. Enhancement of neural stem cell survival, proliferation, migration, and differentiation in a novel self-assembly peptide nanofibber scaffold. Mol. Neurobiol. 54(10):8050–8062, 2017.
Noda, H., H. Takeuchi, T. Mizuno, and A. Suzumura. Fingolimod phosphate promotes the neuroprotective effects of microglia. J. Neuroimmunol. 256(1–2):13–18, 2013.
Norimatsu, Y., T. Ohmori, A. Kimura, S. Madoiwa, J. Mimuro, A. Seichi, et al. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. Am. J. Pathol. 180(4):1625–1635, 2012.
Pébay, A., M. Toutant, J. Prémont, C. F. Calvo, L. Venance, J. Cordier, et al. Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur. J. Neurosci. 13(11):2067–2076, 2001.
Pham, T.-C.T., J. I. Fells Sr., D. A. Osborne, E. J. North, M. M. Naor, and A. L. Parrill. Molecular recognition in the sphingosine 1-phosphate receptor family. J. Mol. Graphics Model. 26(8):1189–1201, 2008.
Pinschewer, D. D., A. F. Ochsenbein, B. Odermatt, V. Brinkmann, H. Hengartner, and R. M. Zinkernagel. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 164(11):5761–5770, 2000.
Shamsi, F., Z. Zeraatpisheh, H. Alipour, A. Nazari, and H. Aligholi. The effects of minocycline on proliferation, differentiation and migration of neural stem/progenitor cells. Int. J. Neurosci. 130(6):601–609, 2020.
Singh, I. N., and E. D. Hall. Multifaceted roles of sphingosine-1-phosphate: How does this bioactive sphingolipid fit with acute neurological injury? J. Neurosci. Res. 86(7):1419–1433, 2008.
Tan, B., Z. Luo, Y. Yue, Y. Liu, L. Pan, L. Yu, and Y. Yin. Effects of FTY720 (fingolimod) on proliferation, differentiation, and migration of brain-derived neural stem cells. Stem Cells Int. 2016.
Wang, J., J. Wang, P. Lu, Y. Cai, Y. Wang, L. Hong, et al. Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis. Biomaterials. 62:76–87, 2015.
Wei, Y., M. Yemisci, H. H. Kim, L. M. Yung, H. K. Shin, S. K. Hwang, et al. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 69(1):119–129, 2011.
Willis, M. A., and J. A. Cohen. Fingolimod therapy for multiple sclerosis. Paper presented at the Seminars in Neurology, 2013.
Zeraatpisheh, Z., E. Mirzaei, M. Nami, H. Alipour, S. Ghasemian, and H. Azari et al. A new and simple method for spinal cord injury induction in mice. Basic Clin. Neurosci. 2020, forthcoming.
Zeraatpisheh, Z., E. Mirzaei, M. Nami, H. Alipour, M. Mahdavipour, P. Sarkoohi, et al. Local delivery of Fingolimod through PLGA nanoparticles and PuraMatrix-embedded neural precursor cells promote motor function recovery and tissue repair in spinal cord injury. Eur. J. Neurosci. 54:5620, 2021.
Zhang, S., X. Zhao, and L. Spirio. PuraMatrix: self-assembling peptide nanofiber scaffolds. Scaffolding Tissue Eng. 2005, 217–238.
Zhang, Y., X. Li, B. Ciric, C.-G. Ma, B. Gran, A. Rostami, and G.-X. Zhang. Effect of fingolimod on neural stem cells: a novel mechanism and broadened application for neural repair. Mol. Ther. 25(2):401–415, 2017.
Acknowledgments
The authors appreciate the support from Shiraz University of Medical Sciences, Shiraz, Iran.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All animal care and experimental procedures were conducted according to the National Institute of Health guidelines on animal care and use and were approved by the Institutional Ethics Committee of Shiraz University of Medical Sciences (approval no. 11659).
Research Involving Human Rights
The article does not contain any studies with human participants by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Stephanie Michelle Willerth oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zeraatpisheh, Z., Shamsi, F., Sarkoohi, P. et al. Effects of FTY720 on Neural Cell Behavior in Two and Three-Dimensional Culture and in Compression Spinal Cord Injury. Cel. Mol. Bioeng. 15, 331–340 (2022). https://doi.org/10.1007/s12195-022-00724-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-022-00724-0